<Disease><Name>CITRULLINEMIA TYPE II, ADULT-ONSET</Name><Synonym>CITRULLINEMIA, ADULT-ONSET TYPE II; CTLN2</Synonym><OMIM><Number>603471</Number><URL>http://omim.org/entry/603471</URL></OMIM><Orphanet><Number>247585</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=247585</URL></Orphanet><Protein><Number>Calcium-binding mitochondrial carrier protein Aralar2, secondary decreased activity of argininosuccinate synthetase</Number><URL>http://www.uniprot.org/uniprot/Q9UJS0</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>7q21.3</Gene><ICD>E72.2</ICD><Summary>rare (&lt;1:2000000, 1:19000 in Japan) ;autosomal recessive ;mutation in the SLC25A13 gene</Summary><Symptoms><symtomp><id>3928</id><symptom>altered consciousness, consciousness disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3321</id><symptom>enuresis nocturna</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3916</id><symptom>episodic course (clinical symptoms)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3200</id><symptom>hyperammonemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>4077</id><symptom>liver steatosis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2223</id><symptom>liver, fatty</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1934</id><symptom>sweating</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1757</id><name>Argininosuccinic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>99.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1940</id><name>Citrulline</name><specimen>plasma</specimen><value>increased</value><min>8.00</min><max>47.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1992</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>19.00</min><max>71.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>9</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>25.00</min><max>80.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1092</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>11.00</min><max>68.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>37</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>45.00</min><max>97.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>278</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>36.00</min><max>110.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>277</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>47.00</min><max>91.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>276</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>41.00</min><max>79.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>275</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>28.00</min><max>56.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>274</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>24.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>273</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>27.00</min><max>59.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>279</id><name>Ammonia</name><specimen>blood</specimen><value>increased</value><min>27.00</min><max>57.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>32</id><name>Argininosuccinic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.50</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1529</id><name>Argininosuccinic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.50</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>27</id><name>Argininosuccinic acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1987</id><name>Argininosuccinic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>99.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>17</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>864</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1759</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>780.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>? Maximum 790 ?</comment></metabolite><metabolite><id>1899</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1900</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1901</id><name>Citrulline</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>16</id><name>Citrulline</name><specimen>plasma</specimen><value>increased</value><min>7.00</min><max>50.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1189</id><name>Citrulline</name><specimen>plasma</specimen><value>increased</value><min>15.00</min><max>55.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1292</id><name>Citrulline</name><specimen>plasma</specimen><value>increased</value><min>7.00</min><max>35.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1293</id><name>Citrulline</name><specimen>plasma</specimen><value>increased</value><min>19.00</min><max>52.00</max><unit>&#956;mol/ml</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>normal/inc</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>8090</id><title>Diabetes mellitus exacerbates citrin deficiency via glucose toxicity</title><author>Watanabe Y,</author><journal>Diabetes Res Clin Pract</journal><year>2020</year><book /><volume>164</volume><number>0</number><pages>108159</pages><co_aut>et al.</co_aut></literature><literature><id>8091</id><title>AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures</title><author>Saheki T,</author><journal>Biomolecules</journal><year>2020</year><book /><volume>10</volume><number>8</number><pages>E1100</pages><co_aut>et al.</co_aut></literature><literature><id>8174</id><title>Metabolic basis and treatment of citrin deficiency</title><author>Hayasaka K</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>6502</id><title>Adult-onset type II citrullinemia: Current insights and therapy</title><author>Hayasaka K,</author><journal>Appl Clin Genet</journal><year>2018</year><book /><volume>11</volume><number>0</number><pages>163-170</pages><co_aut>Numakura C</co_aut></literature><literature><id>4229</id><title>Anesthetic experience of an adult male with citrullinemia type II: a case report</title><author>Choi JJ,</author><journal>BMC Anesthesiol</journal><year>2016</year><book /><volume>16</volume><number>1</number><pages>92</pages><co_aut>et al.</co_aut></literature><literature><id>3840</id><title>Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARalpha</title><author>Komatsu M,</author><journal>Biochim Biophys Acta</journal><year>2015</year><book /><volume>1852</volume><number>3</number><pages>473-481</pages><co_aut>et al.</co_aut></literature><literature><id>3716</id><title>Molecular genetics of citrullinemia types I and II</title><author>Woo HI,</author><journal>Clin Chim Acta</journal><year>2014</year><book /><volume>431</volume><number>0</number><pages>1-8</pages><co_aut>Park HD, Lee YW</co_aut></literature><literature><id>3841</id><title>Three cases of adult-onset type II citrullinemia treated with different therapies: Efficacy of sodium pyruvate and low-carbohyd</title><author>Kogure T,</author><journal>Hepatol Res</journal><year>2014</year><book /><volume>44</volume><number>6</number><pages>707-712</pages><co_aut>et al.</co_aut></literature><literature><id>3717</id><title>Liver transplantation versus conservative treatment for adult-onset type II citrullinemia: our experience and a review of the l</title><author>Kimura N,</author><journal>Transplant Proc</journal><year>2013</year><book /><volume>45</volume><number>9</number><pages>3423-3427</pages><co_aut>et al.</co_aut></literature><literature><id>2978</id><title>A case of adult onset type II citrullinemia with portal-systemic shunt</title><author>Noto D</author><journal>J Neurol Sci</journal><year>2009</year><book /><volume>281</volume><number>0</number><pages>127-129</pages><co_aut>et al.</co_aut></literature><literature><id>2979</id><title>Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruv</title><author>Mutoh K</author><journal>J Inherit Metab Dis</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2980</id><title>Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease</title><author>Komatsu M</author><journal>J Hepatol</journal><year>2008</year><book /><volume>49</volume><number>5</number><pages>810-820</pages><co_aut>et al.</co_aut></literature><literature><id>2982</id><title>An adult with type 2 citrullinemia presenting in Europe</title><author>Fiermonte G</author><journal>N Engl J Med</journal><year>2008</year><book /><volume>358</volume><number>13</number><pages>280-282</pages><co_aut>et</co_aut></literature><literature><id>2981</id><title>[Adult-onset citrullinemia]</title><author>Ikeda S</author><journal>Brain Nerve</journal><year>2007</year><book /><volume>59</volume><number>1</number><pages>59-66</pages><co_aut /></literature><literature><id>1957</id><title>Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients</title><author>Tazawa Y</author><journal>Mol Genet Metab</journal><year>2004</year><book /><volume>83</volume><number>0</number><pages>213-219</pages><co_aut>et al.</co_aut></literature><literature><id>1958</id><title>Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency</title><author>Tamamori A</author><journal>Pediatr Res</journal><year>2004</year><book /><volume>56</volume><number>4</number><pages>608-614</pages><co_aut>et al.</co_aut></literature><literature><id>1262</id><title>Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identif</title><author>Yamaguchi N</author><journal>Hum Mutat</journal><year>2002</year><book /><volume>19</volume><number>2</number><pages>122-130</pages><co_aut>et al.</co_aut></literature><literature><id>1959</id><title>Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idi</title><author>Saheki T</author><journal>J Hum Genet</journal><year>2002</year><book /><volume>47</volume><number>7</number><pages>333-341</pages><co_aut>Kobayashi K</co_aut></literature><literature><id>1261</id><title>Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset ty</title><author>Yasuda T</author><journal>Hum Genet</journal><year>2000</year><book /><volume>107</volume><number>6</number><pages>537-545</pages><co_aut>et al.</co_aut></literature><literature><id>1053</id><title>Genomic structure of the adult-onset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue</title><author>Sinasac DS</author><journal>Genomics</journal><year>1999</year><book /><volume>62</volume><number>2</number><pages>289-292</pages><co_aut>et al.</co_aut></literature><literature><id>1054</id><title>An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia</title><author>Osafune K</author><journal>Intern Med</journal><year>1999</year><book /><volume>38</volume><number>7</number><pages>590-596</pages><co_aut>et al.</co_aut></literature><literature><id>1057</id><title>[Liver transplantation in type II citrullinemia]. </title><author>Tsuboi Y</author><journal>Rinsho Shinkeigaku</journal><year>1999</year><book /><volume>39</volume><number>10</number><pages>1049-1053</pages><co_aut>et al.</co_aut></literature><literature><id>1164</id><title>The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein</title><author>Kobayashi K</author><journal>Nat Genet</journal><year>1999</year><book /><volume>22</volume><number>0</number><pages>159-163</pages><co_aut>et al.</co_aut></literature><literature><id>1055</id><title>Adult-onset type II citrullinemia: clinical pictures before and after liver transplantation</title><author>Kawata A</author><journal>Intern Med</journal><year>1997</year><book /><volume>36</volume><number>6</number><pages>408-412</pages><co_aut>et al.</co_aut></literature><literature><id>1056</id><title>Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation</title><author>Yazaki M</author><journal>Transplantation</journal><year>1996</year><book /><volume>62</volume><number>11</number><pages>1679-1684</pages><co_aut>et al.</co_aut></literature><literature><id>1060</id><title>A search for the primary abnormality in adult-onset type II citrullinemia</title><author>Kobayashi K</author><journal>Am J Hum Genet</journal><year>1993</year><book /><volume>53</volume><number>5</number><pages>1024-1030</pages><co_aut>et al.</co_aut></literature><literature><id>1059</id><title>Increased urinary excretion of argininosuccinate in type II citrullinemia</title><author>Saheki T</author><journal>Clin Chim Acta</journal><year>1987</year><book /><volume>170</volume><number>0</number><pages>297-304</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>